Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response
Autor: | Yi-Feng Wang, Haiming Jiang, Xin-Xin Chen, Zifeng Yang, Zhi-Hong Jiang, Lihua Cai, Xiao-Dong Luo, Cai-Yun Wang, Jing-Guang Lu, Ruifeng Chen, Ming-Rong Yang, Hongxia Zhou, Runfeng Li, Xiao Wu, Huan-Rong Zhang, Yunceng Weng, Lihan Shen |
---|---|
Rok vydání: | 2020 |
Předmět: |
Chemokine
medicine.medical_treatment Pharmaceutical Science Biology Virus Replication medicine.disease_cause Antiviral Agents Virus Madin Darby Canine Kidney Cells Proinflammatory cytokine Microbiology 03 medical and health sciences Alkaloids Dogs Influenza A Virus H1N1 Subtype 0302 clinical medicine Orthomyxoviridae Infections Immunopathology Influenza Human Drug Discovery Influenza A virus medicine Animals Humans Lung 030304 developmental biology Pharmacology 0303 health sciences Innate immune system Anti-Inflammatory Agents Non-Steroidal Pattern recognition receptor Immunity Innate Mice Inbred C57BL Cytokine Complementary and alternative medicine A549 Cells 030220 oncology & carcinogenesis biology.protein Cytokines Molecular Medicine Female Alstonia |
Zdroj: | Phytomedicine. 77:153272 |
ISSN: | 0944-7113 |
DOI: | 10.1016/j.phymed.2020.153272 |
Popis: | Background Alstonia scholaris is a folk medicine used to treat cough, asthma and chronic obstructive pulmonary disease in China. Total alkaloids (TA) from A. scholaris exhibit anti-inflammatory properties in acute respiratory disease, which suggests their possible anti-inflammatory effect on influenza virus infection. Purpose To assess the clinical use of TA by demonstrating their anti-influenza and anti-inflammatory effects and the possible mechanism underlying the effect of TA on influenza A virus (IAV) infection in vitro and to reveal the inhibitory effect of TA on lung immunopathology caused by IAV infection. Methods Antiviral and anti-inflammatory activities were assessed in Madin-Darby canine kidney (MDCK) and A549 cells and U937-derived macrophages infected with influenza A/PR/8/34 (H1N1) virus. Proinflammatory cytokine levels were measured by real-time quantitative PCR and Bio-Plex assays. The activation of innate immune signaling induced by H1N1 virus in the absence or presence of TA was detected in A549 cells by Western blot. Furthermore, mice were infected intranasally with H1N1 virus and treated with TA (50, 25 and 12.5 mg/kg/d) or oseltamivir (60 mg/kg/d) for 5 days in vivo. The survival rates and body weight were recorded, and the viral titer, proinflammatory cytokine levels, innate immune cell populations and histopathological changes in the lungs were analyzed. Results TA significantly inhibited viral replication in A549 cells and U937-derived macrophages and markedly reduced cytokine and chemokine production at the mRNA and protein levels. Furthermore, TA blocked the activation of pattern recognition receptor (PRR)- and IFN-activated signal transduction in A549 cells. Critically, TA also increased the survival rate, reduced the viral titer, suppressed proinflammatory cytokine production and innate immune cell infiltration and improved lung histopathology in a lethal PR8 mouse model. Conclusion TA exhibits anti-viral and anti-inflammatory effects against IAV infection by interfering with PRR- and IFN-activated signal transduction. |
Databáze: | OpenAIRE |
Externí odkaz: |